NGENF
Price
$4.41
Change
+$0.18 (+4.26%)
Updated
Dec 3 closing price
Capitalization
345.43M
Intraday BUY SELL Signals
QCLS
Price
$4.67
Change
+$1.29 (+38.17%)
Updated
Dec 3 closing price
Capitalization
19.46M
Intraday BUY SELL Signals
Interact to see
Advertisement

NGENF vs QCLS

Header iconNGENF vs QCLS Comparison
Open Charts NGENF vs QCLSBanner chart's image
NervGen Pharma
Price$4.41
Change+$0.18 (+4.26%)
Volume$448.66K
Capitalization345.43M
Q/C Technologies
Price$4.67
Change+$1.29 (+38.17%)
Volume$54.71M
Capitalization19.46M
NGENF vs QCLS Comparison Chart in %
NGENF
Daily Signal:
Gain/Loss:
QCLS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NGENF vs. QCLS commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGENF is a Hold and QCLS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (NGENF: $4.14 vs. QCLS: $3.39)
Brand notoriety: NGENF and QCLS are both not notable
NGENF represents the Biotechnology, while QCLS is part of the Computer Processing Hardware industry
Current volume relative to the 65-day Moving Average: NGENF: 147% vs. QCLS: 7%
Market capitalization -- NGENF: $345.43M vs. QCLS: $19.46M
NGENF [@Biotechnology] is valued at $345.43M. QCLS’s [@Computer Processing Hardware] market capitalization is $19.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The market cap for tickers in the [@Computer Processing Hardware] industry ranges from $160.94B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B. The average market capitalization across the [@Computer Processing Hardware] industry is $12.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGENF’s FA Score shows that 0 FA rating(s) are green whileQCLS’s FA Score has 0 green FA rating(s).

  • NGENF’s FA Score: 0 green, 5 red.
  • QCLS’s FA Score: 0 green, 5 red.
According to our system of comparison, NGENF is a better buy in the long-term than QCLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGENF’s TA Score shows that 5 TA indicator(s) are bullish while QCLS’s TA Score has 3 bullish TA indicator(s).

  • NGENF’s TA Score: 5 bullish, 5 bearish.
  • QCLS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, NGENF is a better buy in the short-term than QCLS.

Price Growth

NGENF (@Biotechnology) experienced а +32.69% price change this week, while QCLS (@Computer Processing Hardware) price change was -7.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

The average weekly price growth across all stocks in the @Computer Processing Hardware industry was +2.20%. For the same industry, the average monthly price growth was -10.22%, and the average quarterly price growth was +30.68%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Computer Processing Hardware (+2.20% weekly)

Computer Processing Hardware industry produces central processing unit, monitor, keyboard, computer data storage devices, and graphics card. Business activity and economic growth are potential drivers of this industry – if more businesses are growing or flourishing, so would their investments in computer equipment. Dell Technologies, Inc, Hewlett Packard Enterprise Co., NCR Corporation are key producers of computer processing hardware.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGENF($345M) has a higher market cap than QCLS($19.5M). NGENF YTD gains are higher at: 89.908 vs. QCLS (-97.052). QCLS has higher annual earnings (EBITDA): -8.36M vs. NGENF (-26.41M). NGENF has more cash in the bank: 15.7M vs. QCLS (208K). QCLS has less debt than NGENF: QCLS (0) vs NGENF (57.7K). NGENF (0) and QCLS (0) have equivalent revenues.
NGENFQCLSNGENF / QCLS
Capitalization345M19.5M1,769%
EBITDA-26.41M-8.36M316%
Gain YTD89.908-97.052-93%
P/E RatioN/AN/A-
Revenue00-
Total Cash15.7M208K7,548%
Total Debt57.7K0-
FUNDAMENTALS RATINGS
NGENF vs QCLS: Fundamental Ratings
NGENF
QCLS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
41100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3692
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a4

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QCLS's Valuation (36) in the null industry is somewhat better than the same rating for NGENF (92). This means that QCLS’s stock grew somewhat faster than NGENF’s over the last 12 months.

NGENF's Profit vs Risk Rating (41) in the null industry is somewhat better than the same rating for QCLS (100). This means that NGENF’s stock grew somewhat faster than QCLS’s over the last 12 months.

NGENF's SMR Rating (100) in the null industry is in the same range as QCLS (100). This means that NGENF’s stock grew similarly to QCLS’s over the last 12 months.

NGENF's Price Growth Rating (36) in the null industry is somewhat better than the same rating for QCLS (92). This means that NGENF’s stock grew somewhat faster than QCLS’s over the last 12 months.

NGENF's P/E Growth Rating (100) in the null industry is in the same range as QCLS (100). This means that NGENF’s stock grew similarly to QCLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NGENFQCLS
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
84%
Momentum
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
81%
MACD
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 7 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 17 days ago
82%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
81%
Aroon
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NGENF
Daily Signal:
Gain/Loss:
QCLS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYLIX98.29N/A
N/A
Rydex Leisure Inv
OTCNX82.21N/A
N/A
Invesco Discovery Large Cap R
TQMIX18.59N/A
N/A
AMG TimesSquare Mid Cap Growth I
ICMPX17.71N/A
N/A
Lazard International Quality Gr Instl
TLASX12.90N/A
N/A
Transamerica Large Core ESG R6

NGENF and

Correlation & Price change

A.I.dvisor tells us that NGENF and CYTK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NGENF and CYTK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGENF
1D Price
Change %
NGENF100%
N/A
CYTK - NGENF
25%
Poorly correlated
-3.79%
IBRX - NGENF
23%
Poorly correlated
-9.13%
QCLS - NGENF
22%
Poorly correlated
+0.30%
ATRA - NGENF
22%
Poorly correlated
-9.31%
SGMO - NGENF
21%
Poorly correlated
+4.28%
More

QCLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, QCLS has been loosely correlated with ARTV. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if QCLS jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QCLS
1D Price
Change %
QCLS100%
+0.30%
ARTV - QCLS
47%
Loosely correlated
-3.75%
COGT - QCLS
39%
Loosely correlated
-2.04%
PHAT - QCLS
39%
Loosely correlated
-1.27%
TVGN - QCLS
36%
Loosely correlated
-4.53%
LRMR - QCLS
32%
Poorly correlated
-12.11%
More